Bioventus (NASDAQ:BVS) Updates FY 2026 Earnings Guidance
One daysingle sourceOne outlet reported this, once - no second voice in this corpus.
All 1 reports on Wed, 5 August 2026
What it is about
Bioventus Company ProfileBrooklyn Investment GroupBarrington ResearchMercer Global Advisors IncCanaccord Genuity GroupO Shaughnessy Asset ManagementPrelude Capital ManagementSherbrooke Park AdvisersNorth Carolina, United States
Who published it, and when
How it spread - 1 original report
Wed, 5 August 2026
1 report- themarketsdaily.com19:10first to report
Bioventus (NASDAQ:BVS – Get Free Report) issued an update on its FY 2026 earnings guidance on Wednesday morning. The company provided EPS guidance of 0.750-0.790 for the period, compared to the consensus estimate of 0.770. The company issued revenue guidance of $600.0 million-$610.0 million, compared to the consensus revenue estimate of $605.1 million. Bioventus Trading […]